FFCP PHASE1:Hg19::chr19:56343381..56343389,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=204801 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=22945 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=70bp_to_uc002qmb.2_5end | |||
|description=CAGE_peak_4_at_NLRP11_5end | |||
|id=chr19:56343381..56343389,- | |||
|ontology_enrichment_celltype=CL:0000039!3.66e-35!7;CL:0000586!3.66e-35!7;CL:0000819!7.57e-17!1;CL:0000945!5.15e-16!24;CL:0000826!5.15e-16!24;CL:0000838!2.13e-10!52;CL:0000542!3.39e-10!53;CL:0000051!3.39e-10!53;CL:0000785!4.34e-09!2;CL:0000955!4.34e-09!2;CL:0000818!4.34e-09!2;CL:0000954!4.34e-09!2;CL:0000816!4.34e-09!2;CL:0000815!5.49e-09!2;CL:0000792!5.49e-09!2;CL:0002677!5.49e-09!2 | |||
|ontology_enrichment_celltype_v019=CL:0000785;6.58e-50;1!CL:0000819;6.58e-50;1!CL:0000945;2.67e-09;24!CL:0000039;1.89e-08;7!CL:0000586;1.89e-08;7 | |||
|ontology_enrichment_celltype_v019_2=CL:0000819,6.58e-50,1;CL:0000785,9.18e-26,2;CL:0000955,9.18e-26,2;CL:0000818,9.18e-26,2;CL:0000954,9.18e-26,2;CL:0000816,9.18e-26,2;CL:0000817,1.12e-17,3;CL:0000945,2.67e-09,24;CL:0000826,2.67e-09,24;CL:0000039,1.89e-08,7;CL:0000586,1.89e-08,7 | |||
|ontology_enrichment_development_v019=CL:0000954;9.18e-26;2 | |||
|ontology_enrichment_disease=DOID:0050619!6.47e-17!1;DOID:1357!6.47e-17!1;DOID:0060073!7.57e-17!1;DOID:8675!7.57e-17!1;DOID:3095!1.88e-11!22;DOID:2994!1.88e-11!22;DOID:0060058!3.65e-07!10 | |||
|ontology_enrichment_disease_v019=DOID:0050619;3.99e-50;1!DOID:1357;3.99e-50;1!DOID:0060073;6.58e-50;1!DOID:8675;6.58e-50;1!DOID:0060058;9.44e-21;10 | |||
|ontology_enrichment_disease_v019_2=DOID:0050619,3.99e-50,1;DOID:1357,3.99e-50,1;DOID:0060073,6.58e-50,1;DOID:8675,6.58e-50,1;DOID:0060058,9.44e-21,10 | |||
|ontology_enrichment_uberon=UBERON:0000473!7.85e-31!8;UBERON:0003135!1.50e-22!11;UBERON:0001764!6.47e-17!1;UBERON:0001825!6.47e-17!1;UBERON:0000991!5.53e-12!21;UBERON:0009196!5.53e-12!21;UBERON:0009117!5.53e-12!21;UBERON:0005564!5.53e-12!21;UBERON:0004176!1.88e-11!22;UBERON:0003101!1.88e-11!22;UBERON:0000079!1.88e-11!22 | |||
|ontology_enrichment_uberon_v019=UBERON:0001764;3.99e-50;1!UBERON:0001825;3.99e-50;1!UBERON:0000473;1.49e-07;8 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001764,3.99e-50,1;UBERON:0001825,3.99e-50,1;UBERON:0000473,1.49e-07,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.152826811495903,0.164201178899891,0.314843125254717,0,0,0,0,0,0,6.04244164526353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.294605907474837,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10366105501537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.73682183823499,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.71162288750703,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150962843566674,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.509944148709909,8.8181743737635,0.0918948995348449,0.250707539292375,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p4@NLRP11 | |||
}} |
Revision as of 01:16, 21 January 2014
Short description: | p4@NLRP11 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_NLRP11_5end |
Coexpression cluster: | NA |
Association with transcript: | 70bp_to_uc002qmb.2_5end |
EntrezGene: | NLRP11 |
HGNC: | 22945 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 6.58e-50 | 1 |
mature B cell | 9.18e-26 | 2 |
pre-B-II cell | 9.18e-26 | 2 |
transitional stage B cell | 9.18e-26 | 2 |
small pre-B-II cell | 9.18e-26 | 2 |
immature B cell | 9.18e-26 | 2 |
precursor B cell | 1.12e-17 | 3 |
lymphocyte of B lineage | 2.67e-09 | 24 |
pro-B cell | 2.67e-09 | 24 |
germ line cell | 1.89e-08 | 7 |
germ cell | 1.89e-08 | 7 |
Ontology term | p-value | n |
---|---|---|
maxillary sinus | 3.99e-50 | 1 |
paranasal sinus | 3.99e-50 | 1 |
testis | 1.49e-07 | 8 |
Ontology term | p-value | n |
---|---|---|
paranasal sinus cancer | 3.99e-50 | 1 |
maxillary sinus cancer | 3.99e-50 | 1 |
lymphatic system cancer | 6.58e-50 | 1 |
lymphosarcoma | 6.58e-50 | 1 |
lymphoma | 9.44e-21 | 10 |